
2025 Trends in Life Sciences: Adapting to a Changing Landscape
In 2025, the life sciences industry must navigate rising inflation, a patent expiry cliff, regulatory shifts, and reduced M&A activity. Generative AI and automation are transforming drug discovery and processes, while companies focus on mass-market treatments and telehealth expansion. Strategic pricing and operational optimization will be critical for resilience and growth.